S Hametner

1.6k total citations
10 papers, 128 citations indexed

About

S Hametner is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, S Hametner has authored 10 papers receiving a total of 128 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 8 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in S Hametner's work include Liver Disease Diagnosis and Treatment (7 papers), Liver Disease and Transplantation (6 papers) and Hepatitis C virus research (5 papers). S Hametner is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Liver Disease and Transplantation (6 papers) and Hepatitis C virus research (5 papers). S Hametner collaborates with scholars based in Austria and Germany. S Hametner's co-authors include A Maieron, Monika Ferlitsch, R Schöfl, Michael Trauner, Arnulf Ferlitsch, A Ziachehabi, Péter Ferenci, Markus Peck‐Radosavljevic, Petra Salzl and Thomas Reiberger and has published in prestigious journals such as PLoS ONE, Journal of Hepatology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

S Hametner

8 papers receiving 126 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Hametner Austria 3 120 114 42 8 7 10 128
Eléonora De Martin Italy 7 140 1.2× 107 0.9× 57 1.4× 2 0.3× 3 0.4× 20 165
Cheryl Dale Canada 6 89 0.7× 46 0.4× 65 1.5× 4 0.5× 3 0.4× 7 113
Lennox Jeffers United States 5 60 0.5× 50 0.4× 18 0.4× 6 0.8× 5 0.7× 5 73
Mouna Ben Kilani France 4 208 1.7× 215 1.9× 22 0.5× 4 0.5× 8 1.1× 12 278
Abduljaleel Alalwan Saudi Arabia 8 135 1.1× 137 1.2× 44 1.0× 1 0.1× 3 0.4× 12 190
F. G. Villamil United States 7 140 1.2× 98 0.9× 69 1.6× 2 0.3× 4 0.6× 9 184
Edgar Brodkin United Kingdom 2 125 1.0× 123 1.1× 54 1.3× 3 0.4× 5 138
Eira Cerda Spain 3 77 0.6× 71 0.6× 43 1.0× 2 0.3× 2 0.3× 4 100
L. Muratori Italy 5 198 1.6× 190 1.7× 73 1.7× 1 0.1× 4 0.6× 15 222
Filipe Calinas Portugal 6 70 0.6× 69 0.6× 14 0.3× 3 0.4× 2 0.3× 22 92

Countries citing papers authored by S Hametner

Since Specialization
Citations

This map shows the geographic impact of S Hametner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Hametner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Hametner more than expected).

Fields of papers citing papers by S Hametner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Hametner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Hametner. The network helps show where S Hametner may publish in the future.

Co-authorship network of co-authors of S Hametner

This figure shows the co-authorship network connecting the top 25 collaborators of S Hametner. A scholar is included among the top collaborators of S Hametner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Hametner. S Hametner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Schwarzer, Rémy, Thomas Reiberger, Mattias Mandorfer, et al.. (2019). The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis. Journal of Gastroenterology. 55(5). 533–542. 20 indexed citations
3.
Rutter, Karoline, Monika Ferlitsch, A Maieron, et al.. (2016). von Willebrand factor antigen (vWF-Ag): A non-invasive predictor of treatment response and serious adverse events in HCV patients with interferon triple therapy. Digestive and Liver Disease. 48(10). 1194–1199. 1 indexed citations
5.
Schwarzer, Ralf, S Hametner, A Ziachehabi, et al.. (2016). Therapeutic options in patients with malignant biliary obstruction – a retrospective single center analyze. Zeitschrift für Gastroenterologie. 54(5). 1 indexed citations
7.
Beinhardt, S., C Freissmuth, Ramona Al‐Zoairy, et al.. (2015). LP38 : Efficacy and safety of IFN-free antiviral therapy in patients with HCV recurrence after liver transplantation: real-life experience from austria. Journal of Hepatology. 62. S282–S283. 1 indexed citations
8.
Beinhardt, S., et al.. (2015). Efficacy and safety of IFN-free antiviral therapy in patients with HCV recurrence after liver transplantation: real-life experience from Austria. Zeitschrift für Gastroenterologie. 53(5). 1 indexed citations
9.
Hametner, S, Arnulf Ferlitsch, Monika Ferlitsch, et al.. (2014). P1027 IS THE ELF-SCORE A VALID SUBSTITUTION FOR HVPG TO DETECT CLINICALLY SIGNIFICANT PORTAL HYPERTENSION (CSPH) NON-INVASIVELY?. Journal of Hepatology. 60(1). S417–S417. 1 indexed citations
10.
Maieron, A, Petra Salzl, Markus Peck‐Radosavljevic, et al.. (2013). Von Willebrand Factor as a new marker for non‐invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C. Alimentary Pharmacology & Therapeutics. 39(3). 331–338. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026